Pharmaceutical industry stakeholders suggested some modifications to the US Food and Drug Administration’s (FDA) recently released draft clinical outcome assessments (COA) template for ensuring that ...
Multistakeholder meetings held as part of US Food and Drug Administration (FDA) patient-focused drug development efforts have left a huge impact on everyone involved, according to Theresa Mullin, PhD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results